.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Accenture
Express Scripts
Novartis
Dow
Daiichi Sankyo
Colorcon
Healthtrust
Merck
Queensland Health

Generated: June 24, 2017

DrugPatentWatch Database Preview

CLARAVIS Drug Profile

« Back to Dashboard

What is the patent landscape for Claravis, and when can generic versions of Claravis launch?

Claravis is a drug marketed by Teva Pharms Usa and is included in two NDAs.

The generic ingredient in CLARAVIS is isotretinoin. There are eleven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the isotretinoin profile page.

Summary for Tradename: CLARAVIS

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list2
Bulk Api Vendors: see list36
Clinical Trials: see list18
Patent Applications: see list4,767
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CLARAVIS at DailyMed

Pharmacology for Tradename: CLARAVIS

Ingredient-typeRetinoids
Drug ClassRetinoid
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa
CLARAVIS
isotretinoin
CAPSULE;ORAL076135-002Apr 11, 2003ABRXNoNo► Subscribe► Subscribe
Teva Pharms Usa
CLARAVIS
isotretinoin
CAPSULE;ORAL076356-001Apr 11, 2003ABRXNoNo► Subscribe► Subscribe
Teva Pharms Usa
CLARAVIS
isotretinoin
CAPSULE;ORAL076135-003May 11, 2006ABRXNoNo► Subscribe► Subscribe
Teva Pharms Usa
CLARAVIS
isotretinoin
CAPSULE;ORAL076135-001Apr 11, 2003ABRXNoYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Colorcon
Cantor Fitzgerald
Chubb
Julphar
US Department of Justice
QuintilesIMS
Moodys
Federal Trade Commission
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot